In-depth identification of tumor microenvironment and development of more potent CAR platform targeting CSCs may overcome the raised challenges, as presented in this review.
[Medical Oncology]
Home Newsletters Cell Therapy News Involving Stemness Factors to Improve CAR T-Cell-Based Cancer Immunotherapy
